Atom Investors LP Amarin Corp Plcuk Transaction History

Atom Investors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.66 - $0.91 $151,834 - $209,348	230,053 New	230,053 $200,000
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $143,473 - $229,380	-44,282 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $174,471 - $258,606	44,282 New	44,282 $226,000
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $278,209 - $486,728	-55,310 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $29,688 - $51,302	-6,211 Reduced 10.1%	55,310 $383,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $5.18 Million - $27.9 Million	-1,295,221 Reduced 95.47%	61,521 $246,000
Q4 2019 Feb 13, 2020	SELL	$13.94 - $24.12 $2.12 Million - $3.67 Million	-152,361 Reduced 10.1%	1,356,742 $29.1 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $10.9 Million - $18.2 Million	784,089 Added 108.15%	1,509,103 $22.9 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $11.8 Million - $14.9 Million	725,014 New	725,014 $14.1 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.